See referenced original article on pages 3052–3058, this issue.
Prevention of human papillomavirus-related malignancy: Access is the answer
Article first published online: 24 JUN 2013
Copyright © 2013 American Cancer Society
Volume 119, Issue 16, pages 2953–2955, 15 August 2013
How to Cite
Duska, L. R. and Stoler, M. H. (2013), Prevention of human papillomavirus-related malignancy: Access is the answer. Cancer, 119: 2953–2955. doi: 10.1002/cncr.28180
- Issue published online: 2 AUG 2013
- Article first published online: 24 JUN 2013
- Manuscript Accepted: 1 MAY 2013
- Manuscript Revised: 27 APR 2013
- Manuscript Received: 16 APR 2013
The majority of HPV-related cancers are caused by HPV 16 and HPV 18, but the distribution of these two viral types vary depending on race and socioeconomic status as well as the particular cancer type (cervix versus other). Ultimately, access to preventative care, including widespread pap smear screening for cervical cancer precursors and HPV vaccination, is the answer to eradicating HPV-related disease.